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individuals. Clinical studies are thus much 
needed to examine the diff erential benefi ts 
of endurance versus resistance training for 
sarcopenia, for infl ammation, and for over-
all mortality and morbidity in patients with 
end-stage renal disease. In addition, further 
investigation into the molecular pathogen-
esis of uremic cachexia and sarcopenia may 
reveal novel therapeutic targets for pre-
venting these potentially life-threatening 
complications.
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Dendritic cells: Not just another 
cell type in the kidney, but a 
complex immune sentinel network
C Kurts1
Dendritic cells (DCs) are crucial for inducing and regulating adaptive 
immunity. These cells also exist in the kidney, where, however, their 
function had been unknown. A study by Soos et al. now demonstrates 
that renal DCs form an intricate cellular network that continuously surveys 
the tubulointerstitium, and reveals a previously unrecognized immune 
sentinel system of the kidney.
Kidney International (2006) 70, 412–414. doi:10.1038/sj.ki.5001613
Dendritic cells (DCs) represent one of 
the most extensively studied topics in 
immunology, because of their central 
role in the induction and regulation of 
adaptive immunity, and because of their 
therapeutic potential for manipulating 
immune responses. Most of our knowl-
edge of their physiology was extrapolated 
from in vitro studies, or from in vivo 
analysis of the secondary lymphatics and 
the skin, where DCs are copious and rela-
tively easily accessible. Yet even so, DCs 
reside in virtually all tissues, including 
the kidney. Despite their obvious poten-
tial to contribute to renal infl ammation, 
these cells have received relatively little 
attention so far. Th is may now change, 
as novel transgenic mouse strains have 
become available that greatly facilitate 
their observation in vivo. Th is issue of 
Kidney International features a study by 
Soos et al. that used such a mouse strain 
to reveal an intricate network of DCs that 
appear to patrol the renal tubulointersti-
tium (Figure 1).1 Th e complexity of this 
network is surprising. Evidently, the DCs 
residing in the kidney form an immuno-
surveillance network whose extent has 
not been fully appreciated yet.
The principal DC function is the 
induction of adaptive immune responses, 
in particular those executed by T cells. 
Th eir bone marrow-derived precursors 
enter from the bloodstream as immature 
DCs. Th ese migrate through tissues, col-
lect antigens, and sense ‘danger’ signals 
(pathogen-derived molecular patterns, 
tissue damage, local inflammation). 
Such signals induce DC maturation, 
which results in the loss of phagocytic 
activity and expression of co-stimula-
tory molecules and enhances migration 
to draining lymph nodes, where naive 
T cells await activation. Activated T cells 
leave the lymph nodes in search of the 
antigen source — for example, infectious 
pathogens which they can combat either 
directly or indirectly by stimulating other 
immune eff ectors, such as macrophages. 
In the absence of pathogens, DCs will 
remain immature and fail to upregulate 
co-stimulatory molecules. Autoantigens 
carried by such immature DCs will toler-
ize autoreactive T cells. In this way, DCs 
also maintain peripheral self-tolerance. 
Whether these fundamental principles 
that have been demonstrated for DCs 
in the skin, intestine, pancreatic islets, 
lungs, or liver apply also to renal DCs is 
mostly unknown.
Our lack of knowledge about renal 
DCs is partially due to technical diffi  cul-
ties in detecting and isolating these frag-
ile cells from the kidney. Th us, the fi rst 
convincing evidence for their existence 
was provided not earlier than in 1994, 
when Kaissling and Le Hir observed by 
electron microscopy numerous tubu-
lointerstitial cells with DC morphol-
ogy.2 In the same year, Austyn, Roake, 
and colleagues reported functional 
major histocompatibility complex 
class II+ expression by these cells and their 
ability to induce T-cell allo-activation.3 
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A major controversy with these early 
studies came from the well-described 
expression of macrophage markers, such 
as Mac-1 (also known as CD11b) and 
F4/80, on tubulointerstitial major his-
tocompatibility complex II+ cells, which 
previously had led to their classifi cation 
as resident tissue macrophages. However, 
both markers have long been known to 
be expressed also by particular DC sub-
populations.4 In 2004, tubulointerstitial 
major histocompatibility complex II+ 
cells were shown to co-express the DC 
marker CD11c with these macrophage 
markers. Isolated renal CD11c+ cells pos-
sessed DC functionality, and not that of 
macrophages.5 Th is allowed classifi ca-
tion of these cells as DCs on the basis of 
functional properties. Th e study by Soos 
et al.1 now extends these previous stud-
ies by revealing an intricate tubulointer-
stitial network of cells with dendritic 
morphology that expressed the chemo-
kine receptor CX3CR1, also known as 
the fractalkine receptor. Th is receptor is 
known to be constitutively expressed by 
DC precursors and plays a crucial role in 
mediating their entry into non-lymphoid 
tissues under non-infl ammatory condi-
tions.6 Most CX3CR1
+ cells in the kid-
ney expressed major histocompatibility 
complex II, CD11b, F4/80, and CD11c.1 
Th is phenotype matched that previously 
described for renal DCs,5 allowing clas-
sifi cation of renal CX3CR1
+ cells as DCs. 
Th ese discoveries were achieved with the 
use of CX3CR1
GFP/+ knock-in mice, in 
which DCs were rendered constitutively 
fl uorescent by transgenic expression of 
green fl uorescent protein (GFP), yet still 
expressed CX3CR1.
6 These mice had 
proven extremely valuable for visualiz-
ing DCs in the intestine and in the liver. 
Th e abundance of CX3CR1
+ cells within 
the tubulointerstitium1 suggests a role of 
the fractalkine receptor in immigration 
of DC precursors also into the kidney.
A sub-population of CX3CR1
+ cells 
described by Soos et al. expressed F4/80, 
but not CD11c,1 and thus cannot be 
formally categorized as DCs but may 
theoretically represent macrophages, as 
some of these cells are CX3CR1-depend-
ent as well. Indeed, in a diff erent GFP 
reporter mouse strain, which used the 
macrophage-specific c-fms promoter, 
renal tubulointerstitial F4/80+ cells were 
fl uorescent.7 At fi rst view, this appears 
to be at odds with the conclusion of 
F4/80 expression on DCs.1,5 However, 
the dichotomy between DCs and mac-
rophages has recently become more and 
more blurred, as evidence has accumu-
lated for the mononuclear phagocyte 
hypothesis. Th is theory claims that DCs 
and macrophages represent two func-
tional extremes of a continuum of dif-
ferentiation stages of the same precursor 
cell, most likely the monocyte.8 Th ese 
enter tissues and may diff erentiate later 
into DCs or macrophages, depending 
on the situation and necessities. Strong 
support for this theory came from the 
recent identifi cation of a common DC/
macrophage precursor that expressed 
CX3CR1.
9 Th e theory of the mononuclear 
phagocyte not only is attractive from a 
theoretical point of view but also has the 
potential to clarify unresolved questions 
concerning phagocytes in non-lymphoid 
tissues, such as the kidney. For example, it 
may explain the co-expression of CD11c 
and F4/80 on renal tubulointerstitial 
phagocytes, or why these cells appeared 
fl uorescent both in CX3CR1
GFP/+ ‘DC 
reporter mice’6 and in c-fms–enhanced 
GFP ‘macrophage reporter mice.’7 Th us, 
recent discoveries in basic immunology 
may soon render obsolete the question of 
whether to classify resting mononuclear 
phagocytes as ‘immature DCs’ or as ‘resi-
dent tissue macrophages.’
How to proceed from here? Th e most 
critical question concerns the physiologi-
cal functions of the renal DC network. 
Soos et al. demonstrated by intravital 
fl uorescence microscopy that renal DCs 
constantly probed the environment with 
their dendrites,1 presumably in search 
of antigen. Maybe these cells form a 
reconnaissance network in the kidney 
(Figure 1) that serves to detect infec-
tious pathogens, for example in bacterial 
pyelonephritis. DCs would be strategically 
well positioned to capture antigen from 
bacteria ascending through the tubules. 
Alternatively, others have shown that 
renal DCs take up molecules from the 
tubular lumen,10 suggesting that fi ltrated 
antigens as well may be presented to 
T cells. At present, however, the relevance 
of these two functions remains specula-
tive. Finally, the recently observed repo-
sitioning of DCs to infl amed glomeruli 
in the murine model of nephrotoxic 
nephritis5 suggests an involvement in 
immune-mediated kidney diseases, 
such as glomerulonephritis. To ascer-
tain whether these observations can 
be exploited for diagnostic purposes, it 
appears essential to establish techniques 
for identification of DCs in human 
Figure 1 | Numerous dendritic cells in the tubulointerstitium form an immune sentinel 








414   Kidney International (2006) 70
commentar y
kidney biopsies. Unfortunately, the 
human CD11c molecule is less specifi c 
for DCs than its murine counterpart. 
Nevertheless, many other DC-specifi c 
molecules have been described that may 
be targeted for immunohistochemistry.4
In conclusion, DCs have entered the 
fi eld of renal immunity. Th e availability 
of novel tools to target these cells may 
herald future diagnostic or therapeutic 
opportunities.
REFERENCES
1. Soos TJ, Sims TN, Barisoni L et al. CX3CR1
+ 
interstitial dendritic cells form a contiguous 
network throughout the entire kidney. Kidney 
Int 2006; 70: 591–596. 
2. Kaissling B, Le Hir M. Characterization and 
distribution of interstitial cell types in the renal 
cortex of rats. Kidney Int 1994; 45: 709–720.
3. Austyn JM, Hankins DF, Larsen CP et al. Isolation 
and characterization of dendritic cells from 
mouse heart and kidney. J Immunol 1994; 152: 
2401–2410.
4. Shortman K, Liu YJ. Mouse and human dendritic 
cell subtypes. Nat Rev Immunol 2002; 2: 151–
161.
5. Krüger T, Benke D, Eitner F et al. Identification 
and functional characterization of dendritic 
cells in the healthy murine kidney and in 
experimental glomerulonephritis. J Am Soc 
Nephrol 2004; 15: 613–621.
6. Geissmann F, Jung S, Littman DR. Blood 
monocytes consist of two principal subsets with 
distinct migratory properties. Immunity 2003; 
19: 71–82.
7. Sasmono RT, Oceandy D, Pollard JW et al. 
A macrophage colony-stimulating factor 
receptor-green fluorescent protein transgene 
is expressed throughout the mononuclear 
phagocyte system of the mouse. Blood 2003; 
101: 1155–1163.
8. Hume DA, Ross IL, Himes SR et al. The 
mononuclear phagocyte system revisited. 
J Leukoc Biol 2002; 72: 621–627.
9. Fogg DK, Sibon C, Miled C et al. A clonogenic 
bone marrow progenitor specific for 
macrophages and dendritic cells. Science 2006; 
311: 83–87.
10. Dong X, Swaminathan S, Bachman LA et al. 
Antigen presentation by dendritic cells in renal 
lymph nodes is linked to systemic and local injury 
to the kidney. Kidney Int 2005; 68: 1096–1108.
